(VIANEWS) - Olympic Steel (ZEUS), Selective Insurance Group (SIGI), PacWest Bancorp (PACW) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Olympic Steel (ZEUS)
25.6% sales growth and 28.09% return on equity
Olympic Steel, Inc. processes and distributes metal products in the United States and internationally.
Olympic Steel's sales growth this year is anticipated to be 84.1% and a negative 13.8% for next year.
Year-on-year quarterly revenue growth grew by 122.9%, now sitting on 2.02B for the twelve trailing months.
Volume
Today's last reported volume for Olympic Steel is 41547 which is 54.49% below its average volume of 91301.
Olympic Steel's sales growth for the next quarter is 25.6%. The company's growth estimates for the present quarter and the next is 1193.8% and negative -53.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.09%.
Volatility
Olympic Steel's last day, last week, and last month's current intraday variation average was 1.45%, 0.92%, and 2.07%, respectively.
Olympic Steel's highest amplitude of average volatility was 4.65% (day), 5.74% (last week), and 4.96% (last month), respectively.
Olympic Steel's Stock Yearly Top and Bottom Value
Olympic Steel's stock is valued at $21.05 at 05:22 EST, way below its 52-week high of $40.00 and way above its 52-week low of $13.75.
Olympic Steel's Moving Average
Olympic Steel's worth is below its 50-day moving average of $22.98 and way below its 200-day moving average of $27.35.2. Selective Insurance Group (SIGI)
22.9% sales growth and 16.25% return on equity
Selective Insurance Group, Inc., together with its subsidiaries, provides insurance products and services in the United States.
Selective Insurance Group's sales growth this year is anticipated to be 15.4% and 9.1% for next year.
Year-on-year quarterly revenue growth grew by 11.4%, now sitting on 3.31B for the twelve trailing months.
Volume
Today's last reported volume for Selective Insurance Group is 217437 which is 8.68% above its average volume of 200062.
Selective Insurance Group's sales growth for the next quarter is 22.9%. The company's growth estimates for the ongoing quarter and the next is a negative 23.4% and negative -19.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.25%.
Volatility
Selective Insurance Group's last day, last week, and last month's current intraday variation average was 2.43%, 1.95%, and 1.29%, respectively.
Selective Insurance Group's highest amplitude of average volatility was 3.19% (day), 4.21% (last week), and 2.89% (last month), respectively.
Selective Insurance Group's Stock Yearly Top and Bottom Value
Selective Insurance Group's stock is valued at $78.27 at 05:22 EST, way under its 52-week high of $91.46 and way above its 52-week low of $62.81.
Selective Insurance Group's Moving Average
Selective Insurance Group's value is below its 50-day moving average of $79.54 and under its 200-day moving average of $78.92.3. PacWest Bancorp (PACW)
16.4% sales growth and 15.98% return on equity
PacWest Bancorp operates as the bank holding company for Pacific Western Bank that provides various banking products and services.
PacWest Bancorp's sales growth this year is anticipated to be 11.3% and 9.2% for next year.
Year-on-year quarterly revenue growth grew by 25.9%, now sitting on 1.46B for the twelve trailing months.
Volume
Today's last reported volume for PacWest Bancorp is 1554510 which is 91.18% above its average volume of 813103.
PacWest Bancorp's sales growth for the next quarter is 16.4%. The company's growth estimates for the present quarter and the next is a negative 19.7% and negative -29.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.98%.
Volatility
PacWest Bancorp's last day, last week, and last month's current intraday variation average was 3.48%, 1.22%, and 1.27%, respectively.
PacWest Bancorp's highest amplitude of average volatility was 7.62% (day), 5.35% (last week), and 3.69% (last month), respectively.
PacWest Bancorp's Stock Yearly Top and Bottom Value
PacWest Bancorp's stock is valued at $46.03 at 05:22 EST, way under its 52-week high of $51.72 and way higher than its 52-week low of $29.87.
PacWest Bancorp's Moving Average
PacWest Bancorp's value is below its 50-day moving average of $46.66 and higher than its 200-day moving average of $44.23.4. Mednax (MD)
10.6% sales growth and 8.75% return on equity
MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico.
Mednax's sales growth this year is expected to be 9.3% and 4% for next year.
Year-on-year quarterly revenue growth grew by 7%, now sitting on 1.83B for the twelve trailing months.
Volume
Today's last reported volume for Mednax is 567083 which is 30.78% above its average volume of 433601.
Mednax's sales growth for the next quarter is 10.6%. The company's growth estimates for the present quarter and the next is 76% and 12.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.75%.
Volatility
Mednax's last day, last week, and last month's current intraday variation average was 2.42%, 2.04%, and 1.40%, respectively.
Mednax's highest amplitude of average volatility was 3.65% (day), 3.53% (last week), and 2.72% (last month), respectively.
Mednax's Stock Yearly Top and Bottom Value
Mednax's stock is valued at $24.42 at 05:22 EST, way below its 52-week high of $35.67 and way higher than its 52-week low of $20.27.
Mednax's Moving Average
Mednax's value is under its 50-day moving average of $26.49 and way under its 200-day moving average of $28.84.5. Proto Labs (PRLB)
8.4% sales growth and 4.28% return on equity
Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide.
Proto Labs's sales growth this year is expected to be 10.9% and 8.1% for next year.
Year-on-year quarterly revenue growth grew by 16.6%, now sitting on 469.72M for the twelve trailing months.
Volume
Today's last reported volume for Proto Labs is 549672 which is 14.25% above its average volume of 481072.
Proto Labs's sales growth for the next quarter is 8.4%. The company's growth estimates for the ongoing quarter and the next is a negative 46% and negative -5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.28%.
Volatility
Proto Labs's last day, last week, and last month's current intraday variation average was 2.03%, 0.89%, and 1.72%, respectively.
Proto Labs's highest amplitude of average volatility was 4.51% (day), 3.54% (last week), and 4.17% (last month), respectively.
Proto Labs's Stock Yearly Top and Bottom Value
Proto Labs's stock is valued at $49.35 at 05:22 EST, way below its 52-week high of $286.57 and higher than its 52-week low of $47.57.